News & Events

News

18 March 2019 CE-Mark for VISITECT® CD4 Advanced Disease test

Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that it has CE-Marked its VIS...

06 March 2019 VISITECT CD4 Update

Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that it has received its first...

01 March 2019 Board Appointment

OMEGA DIAGNOSTICS GROUP PLC (“Omega” or the “Company” or the “Group”) Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance...

20 April 2018 Allersys Distribution Agreement

Omega announces that it has signed a global distribuon agreement with Immunodiagnostic Systems Limited for its Allersys® range of allergy assays. Click...

Omega Diagnostics and Burnet Institute announce VISITECT® CD4 CE-Marking

Omega Diagnostics, the medical diagnostics company focused on allergy, food intolerance and infectious disease, is delighted to announce it has successfully...

Grant of US patent for Visitect CD4

Omega has been informed by the Burnet Institute that its exclusively licensed CD4 test for monitoring HIVpositive patients has been awarded a US Patent...

Events

We are pleased to announce our participation at the following events and exhibitions in 2019:

71st AACC ANNUAL SCIENTIFIC MEETING & CLINICAL LAB EXPO

6-8 August 2019
Anaheim, California


MEDICA

18-21 November 2019
Düsseldorf, Germany
Booth number: TBC


20th ICASA CONFERENCE

2-7 December 2019
Kigali, Rwanda
Booth number: TBC